產(chǎn)品資料
            
      
            

      
    
    
      
        產(chǎn)品[
      
            HTB-19 BT-20 人乳癌細(xì)胞
      
        ]資料
      
    
      
        
        
        
    
      
    
      
        
        如果您對(duì)該產(chǎn)品感興趣的話,可以 
            sendmsg
        
      
        產(chǎn)品名稱: 
            HTB-19 BT-20 人乳癌細(xì)胞
      
        產(chǎn)品型號(hào):
        HTB-19
      
        產(chǎn)品廠商:
        美國(guó)標(biāo)準(zhǔn)生物品收藏中心（ATCC）
      
        產(chǎn)品文檔:
        無(wú)相關(guān)文檔
        
        
        
        
      
        
    
      
    
      
    
      
    
      
        
      
            簡(jiǎn)單介紹
        
      
        
      
            
      HTB-19 BT-20 人乳癌細(xì)胞, ATCC 細(xì)胞|細(xì)胞系|細(xì)胞株|腫瘤細(xì)胞|細(xì)胞；細(xì)胞庫(kù)管理規(guī)范，提供的細(xì)胞株背景清楚，提供參考文獻(xiàn)和培養(yǎng)條件！
      
        
      
        
      
        
      
            HTB-19 BT-20 人乳癌細(xì)胞
            的詳細(xì)介紹
        
      
        
      
            
      
	HTB-19 BT-20 人乳癌細(xì)胞

      

      
	
      
		
			
      
				
					ATCC® Number: 
				
				
					HTB-19? 
				
				
					Price: 
				
				
					 
				
			
      
			
      
				
					
      
						
							
      
								
									Designations: 
								
								
									BT-20
								
							
      
							
      
								
									Depositors: 
								
								
									EY Lasfargues 
								
							
      
							
      
								
									Biosafety Level:
								
								
									1
								
							
      
							
      
								
									Shipped: 
								
								
									frozen 
								
							
      
							
      
								
									Medium & Serum: 
								
								
									See Propagation
								
							
      
							
      
								
									Growth Properties:
								
								
									adherent
								
							
      
							
      
								
									Organism:
								
								
									Homo sapiens
								
							
      
							
      
								
									Morphology:
								
								
									epithelial
      

      
      
								      		
							
      
							
      
								
									Source:
								
								
									Organ: mammary gland; breast 
      
Disease: carcinoma      
								      		
							
      
							
      
								
									Permits/Forms:
								
								
									In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
								
							
      
							
      
								
									Isolation: 
								
								
									Isolation date: 1958
								
							
      
							
      
								
									Applications:
								
								
									BT-20 cells are negative for estrogen receptor, but do express an estrogen receptor mRNA that has deletion of exon 5. 
      
This breast tumor line was established by E.Y. Lasfargues and L. Ozzello in 1958 by isolation and cultivation of cells spilling out of the tumor when it was cut in thin slices.      
								      		
							
      
							
      
								
									Tumorigenic:
								
								
									Yes
								
							
      
							
      
								
									Reverse Transcript:
								
								
									negative 
								
							
      
							
      
								
									Antigen Expression:
								
								
									HLA A1, Bw16 (+/-)
								
							
      
							
      
								
									DNA Profile (STR):
								
								
									Amelogenin: X 
      
CSF1PO: 12 
      
D13S317: 11 
      
D16S539: 11,14 
      
D5S818: 12 
      
D7S820: 10 
      
THO1: 7,9.3 
      
TPOX: 11 
      
vWA: 16,17      
								      		
							
      
							
      
								
									Cytogenetic Analysis:
								
								
									Normal chromosomes N3, N4, N9, N13, N14, and X may be absent. The markers der(11)t(11;?)(q25;?) (M1); der(1)t(1;3)(p22?;p13?) (M2); and der(2)t(2;?) (q37;?) (M5) were detected by W.A. Nelson-Rees, et al., Int. J. Cancer 16: 74-85, 1975.
								
							
      
							
      
								
									Isoenzymes: 
								
								
									AK-1, 1-2 
      
ES-D, 1 
      
G6PD, B 
      
GLO-I, 1-2 
      
PGM1, 1 
      
PGM3, 1      
								      		
							
      
							
      
								
									Age: 
								
								
									74 years 
								
							
      
							
      
								
									Gender: 
								
								
									female 
								
							
      
							
      
								
									Ethnicity: 
								
								
									Caucasian 
								
							
      
							
      
								
									Comments:
								
								
									The cells express the WNT3 and the WNT7B oncogenes [PubMed: 8168088]. 
      
This breast tumor line was established by E.Y. Lasfargues and L. Ozzello in 1958 by isolation and cultivation of cells spilling out of the tumor when it was cut in thin slices. A mycoplasma contaminant was discovered and eliminated early in 1972. 
      
Growth of BT-20 cells is inhibited by tumor necrosis factor alpha (TNF alpha). 
      
BT-20 cells are negative for estrogen receptor, but do express an estrogen receptor mRNA that has deletion of exon 5.      
								      		
							
      
							
      
								
									Propagation: 
								
								
									ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
      
Atmosphere: air, 95%; carbon dioxide (CO2), 5% 
      
Temperature: 37.0°C      
								      		
							
      
							
      
								
									Subculturing: 
								
								
									Protocol:  
									
        
										
      1. 
											Remove and discard culture medium.
										
        2. 
										
      2. 
											Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
										
        3. 
										
      3. 
											Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
        
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
										
        4. 
										
      4. 
											Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
										
        5. 
										
      5. 
											Add appropriate aliquots of the cell suspension to new culture vessels.
										
        6. 
										
      6. 
											Incubate cultures at 37°C.
										
        7. 
									
      

      
Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended 
      
Medium Renewal: 2 to 3 times per week      
								      		
							
      
							
      
								
									Preservation: 
								
								
									Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO 
      
Storage temperature: liquid nitrogen vapor phase      
								      		
							
      
							
      
								
									Related Products:
								
								
									Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2003
      
recommended serum:ATCC 30-2020      
								      		
							
      
							
      
								
									References:
								
								
									21405: Sugarman BJ, et al. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230: 943-945, 1985. PubMed: 3933111
      
22536: Fogh J, et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 58: 209-214, 1977. PubMed: 833871
      
23079: Lan MS, et al. Polypeptide core of a human pancreatic tumor mucin antigen. Cancer Res. 50: 2997-3001, 1990. PubMed: 2334903
      
23110: Castles CG, et al. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res. 53: 5934-5939, 1993. PubMed: 8261406
      
23113: Huguet EL, et al. Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res. 54: 2615-2621, 1994. PubMed: 8168088
      
23212: Lasfargues EY, Ozzello L. Cultivation of human breast carcinomas. J. Natl. Cancer Inst. 21: 1131-1147, 1958. PubMed: 13611537
      
23226: Pollack MS, et al. HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines. J. Natl. Cancer Inst. 66: 1003-1012, 1981. PubMed: 7017212
      
32275: Littlewood-Evans AJ, et al. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 57: 5386-5390, 1997. PubMed: 9393764
      
32488: Geiger T, et al. Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice. Anticancer Drug Des. 13: 35-45, 1998. PubMed: 9474241      
								      		
							
      
						      
					
      
				      		
			
      
		      
	
      


      
    
      
        產(chǎn)品留言
    
      
    
      
        
      
            標(biāo)題
            
      
                
            
      
        
      

        
      
            聯(lián)系人
            
      
                
            
      
        
      
        
      
            聯(lián)系電話
            
      
                
            
      
        
      
        
        
      
            內(nèi)容
            
      
                
            
      
        
      
        
      
            驗(yàn)證碼
            
      
                
            
      
            
            點(diǎn)擊換一張
        
      
        
      
            
            
        
      
        
      
            注：1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
      2.如有必要,請(qǐng)您留下您的詳細(xì)聯(lián)系方式!
        
      
    
      

      
      
        
      
    
      

      
            
      
            

        
      
        
      
            

      
    聯(lián)系我們

      

      
    

      

      

      
            

      
    產(chǎn)品搜索

      

      
    
      
        
   
      細(xì)胞系，ATCC細(xì)胞，ATCC菌種，細(xì)胞系目錄，ATCC，鼠傷寒沙門氏菌，atcc細(xì)胞庫(kù)，人**瘤細(xì)胞，人食管癌細(xì)胞，ATCC 19404，ATCC 25922，ATCC 19146，微生物菌種，細(xì)胞株，標(biāo)準(zhǔn)菌株，ATCC中國(guó)，atcc上海代理，CMCC 菌株，ATCC菌株，細(xì)胞目錄，質(zhì)控菌株，腫瘤細(xì)胞株，乳腺癌細(xì)胞系，人肝癌細(xì)胞系
      
      
    
      
    
    

      

      

      
            

      
    產(chǎn)品目錄

      

        
      
    
      

      

      
    
      
        
      
        
      
        
      
        
      
    
      

      

      
    
      
        
    
      

      

      
    
      
    
      

      

      
    
      
        

      
    
    
      
    Copyright? 2003-2025 
    上海復(fù)祥生物科技有限公司版權(quán)所有     
         
    電話：021-35080510
      
    傳真：021-35080520   
    地址：上海市虹口區(qū)赤峰路630號(hào)南雁大廈1901室   
    郵編：
    滬ICP備10013034號(hào)-3  

      

      
        

      
      
            

      
    
      

      

      
        
        
        
        
    

      
    
	
      
		 		
      滬公網(wǎng)安備 31010902002429號(hào)
      
		 	
      
		 



天天拍夜夜添久久精品|
久久国产加勒比精品无码|
国产亚洲精品2021自在线|
亚洲国产欧美日韩精品一区二区三区
|
久久久国产精品福利免费|
久草视频精品在线|
四虎精品影库4HUTV四虎|
日韩乱码人妻无码中文字幕|
日韩精品无码成人专区|
欧美日韩精品一区二区在线观看|
精品久久久久香蕉网|
久久青青草原精品国产|
久久国产乱子伦精品免费看|
中文字幕精品一区二区精品|
久久久久久国产精品无码下载|
亚洲精品99久久久久中文字幕|
久久精品日韩一区国产二区
|
精品大臿蕉视频在线观看|
免费观看国产精品|
国产精品国三级国产AV|
国产精品香蕉成人网在线观看|
精品国产日韩亚洲一区91
|
久久精品免费网站网|
国产精品女人呻吟在线观看
|
久久精品国产精品亚洲艾|
久久777国产线看观看精品|
亚洲永久精品ww47|
中文精品无码中文字幕无码专区|
欧亚精品卡一卡二卡三|
精品aⅴ一区二区三区|
精品aⅴ一区二区三区|
国内精品久久久人妻中文字幕|
亚洲精品国产美女久久久|
国内精品久久久久|
久久福利青草精品资源站免费|
国内精品伊人久久久久|
久久精品一区二区|
亚洲国产精品无码一线岛国|
久久久精品2019中文字幕之3|
午夜精品久久久久久99热|
亚洲国产成人精品不卡青青草原|